OncoSil Medical LtdASX: OSL

OncoSil FY21 half yearly review

· Issued by OncoSil Medical Ltd

Filed with ASX · · 3 pages · English

Sydney, Australia–18 January 2021:OncoSil Medical Ltd (ASX: OSL) (OncoSilor theCompany) would like to provide a review of the Company’s operating activities over the first half of financial year 2021 (1H FY21). Building Organisational Capability OncoSil Medical employed Nigel Lange as President EMEA to head up the activities in the EMEA region. Nigel Lange has deep experience in interventional onc

OncoSil Medical Ltd on 6ix

Earlier from OncoSil Medical

Later from OncoSil Medical

All OncoSil Medical news releases